The study will be a non-randomized, open label, single dose, placebo control, single center, and single arm study in healthy subjects. The study will include one administration of placebo and four single administrations of Oshadi D in two different dose levels, administered in two feeding regimen for the evaluation of the influence of food on Oshadi D absorption.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
8
oral administration
Assaf Harofe Medical Center,
Zrifin, Israel
DNase activity level (Kunitz/mL) for 2 dose levels, and different food regimen
Time frame: 24 hours
Maximum plasma DNase concentration (ng/mL) in different food regimen and dose levels
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.